Blueprint Medicines
BPMC
#2414
Rank
HK$47.74 B
Marketcap
HK$751.65
Share price
-3.25%
Change (1 day)
63.49%
Change (1 year)

Operating Margin for Blueprint Medicines (BPMC)

Operating Margin as of November 2024 (TTM): -29.33%

According to Blueprint Medicines 's latest financial reports and stock price the company's current Operating Margin is -29.33%. At the end of 2023 the company had an Operating Margin of -193.29%.

Operating Margin history for Blueprint Medicines from 2015 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-193.29%-25.39%
2022-259.06%-26.44%
2021-352.17%-1005.47%
202038.89%-107.16%
2019-543.25%-2.09%
2018-554.86%-21.4%
2017-705.90%172.18%
2016-259.35%-43.22%
2015-456.78%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-67.36% 129.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-34.14% 16.40%๐Ÿ‡บ๐Ÿ‡ธ USA
-218.03% 643.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-226.57% 672.49%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.